[Cardiotoxicity in anthracycline chemotherapy: significance of infusion durations. Analysis of a Cochrane review].
Appel
Jon Michael
JM
Herlev Hospital, Kardiologisk Afdeling. jomiap02@heh.regionh.dk
Rybjerg
Marianne
M
Nielsen
Dorte Lisbet
DL
D000328:Adult; D018943:Anthracyclines / Q000008:administration & dosage / Q000009:adverse effects*; D000903:Antibiotics, Antineoplastic / Q000008:administration & dosage / Q000009:adverse effects*; D002648:Child; D019317:Evidence-Based Medicine; D006321:Heart / Q000187:drug effects*; D006333:Heart Failure / Q000139:chemically induced; D006801:Humans; D015201:Meta-Analysis as Topic; D009369:Neoplasms / Q000188:drug therapy* / Q000401:mortality; D012307:Risk Factors; D013997:Time Factors
D018943:Anthracyclines; D000903:Antibiotics, Antineoplastic